# Transparency Life Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transparency-life-sciences

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.transparencyls.com
- Total disclosed funding: $5M
- Latest round: Series A (Feb 15, 2018)
- Investors on record: 1

## About

Transparency Life Sciences is focused on enhancing operational efficiency through innovative software solutions that improve data management and compliance across multiple industries.Founded in 2012 and headquartered in New York, US, Transparency Life Sciences, LLC specializes in providing software solutions that enhance operational efficiency in various sectors. The company raised USD 5.00 mn in Series A funding on February 15, 2018, led by Scientia Ventures, achieving a total of USD 5.00 mn raised to date. Pablo Graiver is the CEO of the company.Transparency LS specializes in providing software solutions aimed at enhancing operational efficiency and compliance in various industries. The company's core offerings include a suite of tools designed for data transparency and workflow optimization, which enable businesses to manage their processes with greater accuracy and effectiveness. Their products focus on addressing challenges related to data management, regulatory compliance, and operational visibility, ensuring that clients can meet industry standards and improve productivity. Transparency LS serves a diverse client base, including enterprises in finance, healthcare, and manufacturing sectors, facilitating better decision-making through real-time insights. Their solutions are deployed in markets across North America and Europe, where businesses increasingly prioritize transparency and accountability in their operations.Transparency LS generates revenue primarily through subscription-based models, allowing clients to access their software solutions on a recurring basis. Clients typically enter into annual contracts that provide them with ongoing access to the tools, updates, and support services, fostering long-term partnerships. Additionally, the company engages in direct-to-consumer transactions, focusing on small and mid-sized enterprises seeking effective compliance solutions. The pricing structure is tiered, offering different service levels based on the features required, with flagship products designed to meet varying client needs. These pricing plans ensure that businesses of all sizes can implement Transparency LS's offerings in a manner that aligns with their operational requirements and budget.Looking ahead, Transparency Life Sciences plans to expand its portfolio with new products aimed at addressing the evolving needs of its clients, with anticipated launches scheduled for late 2023. The company is also targeting expansion into additional markets in Europe and Asia by 2024, capitalizing on the increasing demand for compliance-focused software solutions. The recent Series A funding of USD 5.00 mn will be utilized to support these initiatives, enhancing product development efforts and facilitating market entry strategies.

## Funding rounds

- Series A, Feb 15, 2018, $5M — Scientia Ventures

## Investors

- Scientia Ventures (https://capitalatlas.ai/funds/scientia-ventures) — Series A